Product Information
TEMAZEPAM 30 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0922 per EA under NDC 67877014705. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
30 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877014705
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TEMAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA071457On Market Since
4/21/1987
Pharmacological Classes
Price Statistics
The NADAC for TEMAZEPAM 30 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 19.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0922 per EA |
|---|---|
| All-time high | $0.1075 (Sep 15, 2021) |
| All-time low | $0.0689 (Apr 18, 2018) |
| 52-week high | $0.0946 |
| 52-week low | $0.0894 |
| Median price | $0.0882 |
| Average price | $0.0877 |
| Largest weekly change | -20.4% (Nov 20, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMAZEPAM 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 30 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $0.0922 per EA (NDC 67877014705), effective Jun 24, 2026.
How has the price of TEMAZEPAM 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMAZEPAM 30 MG CAPSULE has risen 19.1%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TEMAZEPAM 30 MG CAPSULE?
Since Nov 28, 2013, the NADAC for TEMAZEPAM 30 MG CAPSULE has ranged from a low of $0.0689 (Apr 18, 2018) to a high of $0.1075 (Sep 15, 2021), with a median of $0.0882 per EA.
Are there cheaper alternatives to TEMAZEPAM 30 MG CAPSULE?
4 NADAC-published products share the same active ingredient, strength, and dosage form as TEMAZEPAM 30 MG CAPSULE, but none are currently priced below it.
Who manufactures TEMAZEPAM 30 MG CAPSULE?
TEMAZEPAM 30 MG CAPSULE (NDC 67877014705) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification